Uncategorized
The recent revelation of the potential of two new groups of drugs viz. angiotensin receptor neprilysin inhibitors (ARNI) and sodium glucose transporter-2 (SGLT-2) inhibitors, with their repertoire extending beyond the thresholds of left ven- tricular ejection fraction (LVEF), has raised a new conun - drum — is LVEF a holy grail in the management of heart failure (HF) More Info https://url-shortener.me/CB4L
Heart Disease is perceived by many to be the disease of men. Actually, cardiovascular diseases remains the leading cause...
Learn more